Greg is the Head of Functional Genomics,
Neuroscience Division at the
Garvan Institute of Medical Research, and a
NHMRC CDF Fellow, and Associate Professor at
the University of Sydney
At the Garvan Institute Greg employs a functional genomics approach, complemented with bioinformatics analysis, to find and characterize novel conserved genes participating in human diseases. He has a primary focus on the conserved genomics of chronic pain perception. More recently he has initiated similar projects targeting lifespan extension, or preventing neurological diseases that increase with age including age-related dementia, Alzheimer's disease, Parkinson's disease and ALS. His work has helped to identify and validate novel human disease genes and discover new potential therapies. Greg is1 of 7 board of governors for the pain genetics SAG of the International Association for the Study of Pain the major international organization devoted to pain research, and acts as an external reviewer for multiple journals (Neuron, Pain, Journal of Immunology, Nature Methods, Current Biology etc.) and granting agencies, and is an invited member of the Australian federal NHMRC assigners academy and the CIHR panel on High Fatality Cancers.